# Using Next-generation Sequencing in the Diagnosis of Epilepsy and/or Intellectual Disability in a Pediatric Cohorte

> **NCT05193890** · — · COMPLETED · sponsor: **Central Hospital, Nancy, France** · enrollment: 69 (actual)

## Conditions studied

- Epilepsy
- Intellectual Disability

## Interventions

- **GENETIC:** retrospective analysis of a panel result

## Key facts

- **NCT ID:** NCT05193890
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-01
- **Primary completion:** 2021-05-31
- **Final completion:** 2021-05-31
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2022-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05193890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05193890, "Using Next-generation Sequencing in the Diagnosis of Epilepsy and/or Intellectual Disability in a Pediatric Cohorte". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05193890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*